Cargando…
Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion
We report about a case of a compassionate off-label use of the anti-interleukin-5-agent mepolizumab in a ventilated patient with life-threatening asthma attack in eosinophilic asthma. The patient suffered from severe eosinophilic asthma and was transmitted to our hospital with an asthma attack and a...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715903/ https://www.ncbi.nlm.nih.gov/pubmed/31485410 http://dx.doi.org/10.1016/j.rmcr.2019.100927 |